Skip to main content
. 2019 Mar 12;59(2):755–766. doi: 10.1007/s00394-019-01942-5

Table 3.

Menopausal symptoms at baseline and following 12 weeks’ soy drink intervention

Treatment group Low (n = 34) Medium (n = 35) High (n = 27)
Greene’s Climacteric Scale Baseline Week 12 Change from baseline Baseline Week 12 Change from baseline Baseline Week 12 Change from baseline
Psychological score 18.29 ± 4.00a 17.47 ± 4.37 − 0.83 ± 5.10 18.51 ± 4.92 16.40 ± 4.11 − 2.11 ± 4.19 17.02 ± 3.55 15.93 ± 3.59 − 1.10 ± 3.89
Vasomotor score 4.46 ± 1.58 3.97 ± 1.73 − 0.49 ± 1.18 4.50 ± 1.54 3.49 ± 1.27 − 1.01 ± 1.84 3.54 ± 1.22 3.37 ± 1.69 − 0.17 ± 2.02
Somatic score 9.79 ± 1.81 9.29 ± 2.28 − 0.49 ± 2.50 9.71 ± 2.30 9.49 ± 2.13 − 0.23 ± 2.68 9.77 ± 2.64 9.26 ± 3.37 − 0.51 ± 3.52
Total score 34.72 ± 5.37 32.76 ± 6.52 − 1.96 ± 6.83 34.87 ± 7.31 31.29 ± 6.10 − 3.58 ± 6.87 32.52 ± 6.42 30.52 ± 7.91 − 2.00 ± 8.62

No significant differences were observed between the groups for any of the symptoms assessed as determined using a Kruskal–Wallis test

aMean ± SD (all such values)